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During assembly of the herpes simplex type 1 capsid, the major capsid protein VP5 interacts with the C-terminal residues
of the scaffold proteins encoded by UL26 and UL26.5. Subsequent to capsid assembly the scaffold proteins are cleaved at
the maturation site by a serine protease also encoded by UL26, thereby enabling the bulk of the scaffold proteins to be
released from the capsid. Previously, a mutant virus (KUL26-610/611) was isolated in which this maturation cleavage site was
blocked by replacing the Ala/Ser at the 610/611 cleavage site by Glu/Phe. This mutation was lethal and required a
transformed cell line expressing wild-type UL26 gene products for growth. Although the mutation was lethal, spontaneous
reversions occurred at a high frequency. Previously, a small number of revertants were isolated and all were found to have
second-site mutations in VP5. The purpose of the present study was to do a comprehensive determination of the sites altered
in VP5 by the second-site mutations. To do this, an additional 25 independent spontaneous revertants were characterized.
Seven of the 25 arose by GC3 GT changes in codon 78, giving rise to an alanine to valine substitution. Four were the result
of base changes at codon 34 but two different amino acids were produced as the changes were at different positions in the
codon. Two mutations were detected at position 41 and mutations that occurred once were found at codons 69 and 80. Thus,
15 of the 25 second-site mutants were localized to codons 34 to 80 of VP5, which contains 1374 amino acids. The remaining
10 revertants had codon changes at nine different sites, of which the most N-terminal was altered at codon 187 and the most
C-terminal at codon 1317. As noted in the much smaller study a preponderance of the second-site mutants in VP5 were
altered in codons at the extreme N-terminus of VP5. It is especially noteworthy that 11 out of 25 of the mutations occurred
at codons 34 and 78. As expected, all of the revertants isolated were shown to retain the original KUL26-610/611 mutation,
and the scaffold proteins remain uncleaved. All showed decreased retention of VP24 in the B capsids compared to the
wild-type KOS, but more than the KUL26-610/611 parental virus. The revertants all had decreased growth rates of 2 to 18%
compared to that of KOS and showed varying degrees of sensitivity when grown at 39.5°C. The mutations in VP5 of three
of the previously isolated viruses (PR5, PR6, and PR7) were transferred into a wild-type background, i.e., a virus encoding
wild-type UL26 and UL26.5 gene products. All replicated in nonpermissive (Vero) cells and cleaved scaffold proteins. PR5 and
PR6 in the wild-type background gave wild-type burst sizes and gave C-capsids that retained VP24 at approximately wild-type
levels. The third revertant, PR7, in the wild-type background showed only a twofold increase of burst size (to 20% of wild-type)
and the capsids showed little or no increase of VP24 retention. Therefore, the second-site mutations of PR7 (R69C) by itself
had a negative effect on virus replication. By contrast the temperature sensitivity of PR6 and PR7 remained unchanged in the
wild-type background. Thus the temperature sensitivity of PR6 and PR7 resides in VP5 independently of the mutation in the
UL26 cleavage site. © 2000 Academic Press
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Integral to the production of infectious herpes simplex
virions is the assembly of the icosahedral capsid that
encloses the viral DNA. Three types of capsids are typ-
ically isolated from infected cells following sedimenta-
tion through sucrose gradients, designated “A,” “B,” and
“C” capsids, depending on the sedimentation distance in
these gradients (Gibson and Roizman, 1972). The “C”
capsids, which sediment farthest, contain viral DNA and
1 1
t
To whom correspondence and reprint requests should be ad-
ressed. Fax: (410) 955-3023. E-mail: pdesai@jhmi.edu.
217are therefore likely to be capsids that will mature into
infectious virions. The “B” capsids do not contain DNA,
but do contain the scaffold proteins and are believed to
be an early stage of viral assembly. The “A” capsids are
empty, containing neither DNA nor scaffold proteins.
These are thought to be capsids that failed in the pack-
aging process.
Seven proteins have been isolated from the “B” cap-
sids. Their designation and the open reading frames
(ORFs) that encode them are VP5 (UL19), VP19C (UL38),
21 (UL26), 22a (UL26.5), VP23 (UL18), VP24 (UL26), and
VP26 (UL35)(Cohen et al., 1980; Gibson and Roizman,972; Heilman et al., 1979; McGeoch et al., 1988). Pro-
eins designated VP are proteins that are present in
0042-6822/00 $35.00
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218 WARNER, DESAI, AND PERSONmature viral particles, whereas the other proteins are lost
in the subsequent maturation process.
Before or concurrent with packaging the DNA, the
scaffold proteins are released from the capsid. The nor-
mal process of release of the scaffold involves the cleav-
age of proteins designated 21 and 22a at a site between
Ala and Ser located at residues 610 and 611 (Fig. 1) of the
UL26 and UL26.5 ORFs (DiIanni et al., 1993). Because the
UL26.5 ORF is the same as the C-terminal (residues
307–635) half of the UL26 ORF, for clarity the amino acid
residue designations for the UL26 ORF are used through-
out this paper for all UL26 and UL26.5 gene products.
The cleavage site between residues 610 and 611 has
been termed the maturation cleavage site and is cut by
a viral serine protease (VP24) also encoded by the UL26
ORF (Liu and Roizman, 1991, 1993; Preston et al., 1992;
Weinheimer et al., 1993). The proteases of herpes viruses
ere discovered concurrently by Gibson and colleagues
Welch et al., 1991) for simian cytomegalovirus (strain
olburn) and by Liu and Roizman (1991) for HSV-1. A
utant virus (KUL26-610/611) was previously isolated
hat had the Ala/Ser at 610/611 changed to Glu/Phe at
his cleavage site, so that the protease was no longer
ble to cleave this site (Person and Desai, 1998). This
utation was lethal and required a transformed cell line
xpressing UL26 and UL26.5 gene products to grow.
dditionally, the amount of VP24 retained in the “B” cap-
ids of this mutant was decreased compared to the
mount retained in the wild-type (KOS) capsids. Subse-
uently, it was observed that, when KUL26-610/611 was
lated on Vero (nonpermissive) cells, small plaques
rose on these cells (Desai and Person, 1999). These
mall plaques were revertant viruses since they contin-
ed to form small plaques when replated on Vero cells.
he frequency of reversion was calculated to be 1:3800.
nitially, nine revertant viruses were isolated and charac-
erized (Desai and Person, 1999). All of these viruses
ere found to contain second mutations in VP5 allowing
FIG. 1. Gene products of the UL26 and UL26.5 ORFs. UL26 encodes
a 635-residue protein with autocatalytic protease activity that cleaves
between residues 247 and 248 (protease release site) to generate
VP24 and 21. 22a is encoded by UL26.5 which is transcribed from a
separate message initiated approximately 1000 nucleotides 39 to that of
L26. Translation begins at codon 307 in the same ORF as UL26. Both
1 and 22a are cleaved by the protease between residues 610 and 611
scaffold maturation site).he virus to grow on untransformed Vero cells, even
hough the maturation cleavage site of UL26 remained
l
Kblocked. The 25 amino acids C-terminal to the matura-
tion cleavage site specified by UL26 and UL26.5 ORF are
necessary and sufficient for interaction with VP5 during
capsid formation (Desai and Person, 1996; Hong et al.,
1996; Kennard et al., 1995; Thomsen et al., 1995). There-
fore, these second-site mutations in VP5 alter this inter-
action and allow the release of the scaffold proteins so
capsid maturation can continue.
The purpose of the present study was to obtain a
comprehensive determination of the sites in VP5 that,
when changed, altered its interaction with the scaffold
proteins. Although the sites of interaction in the scaffold
proteins were localized to residues 622 through 633 of
UL26, (Hong et al., 1996), the sites of interaction in VP5
re essentially unidentified. A goal of the present inves-
igation was to use a genetic analysis to identify residues
f VP5 that may be involved in these interactions. To do
his, 28 additional mutants were isolated and the occur-
ence, distribution, and characteristics of these mutants
re reported here.
RESULTS
evertants are the result of second-site mutations
The goal of these experiments was to isolate a large
umber of revertant viruses of KUL26-610/611, to obtain a
omprehensive map of the sequences of the major cap-
id protein (VP5) that, when altered, would allow virus
eplication in the absence of protease cleavage of the
caffold proteins. To do this, sufficient mutant virus
KUL26-610/611) was plated on the permissive cell line
C32) so as to give 15 to 20 wells with single plaques in
96-well tray. Single plaques were harvested and plated
n nonpermissive Vero cells to detect revertant viruses,
.e., viruses that no longer required the C32 cell line for
rowth. Twenty-eight spontaneous revertants, desig-
ated PR10–PR47, were isolated. PR1–PR9 were num-
ers given to spontaneous revertants isolated by Desai
nd Person (1999). Revertants were generally detected at
rate of 1 in 3800, so not all viruses that formed plaques
n C32 contained a revertant virus. In addition, some of
he plaques were lost in the subsequent rounds of puri-
ication; therefore the numbers extend beyond PR37
nine original plus 28 new viruses), to PR47.
The parental virus (KUL26-610/611) was mutated at
esidues 610 and 611, to block the maturation cleavage
ite; the mutation also resulted in the creation of an
coRI restriction site at this location. To confirm that the
utations were the result of a second-site mutation, a
59-bp C-terminal fragment of UL26 was amplified by
CR and then cut with EcoRI (Fig. 2). In wild-type DNA
here was no EcoRI restriction endonuclease site in the
CR-amplified fragment, so that treatment with EcoRI did
ot change the mobility of the fragment for KOS (compareane 3 to lane 2). The introduction of an EcoRI site into
UL26-610/611 should produce fragments of 247 and 416
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219INTERACTIONS BETWEEN HSV-1 VP5 AND SCAFFOLDbp if the site was retained in the DNA of the revertant
viruses. This was the case for PR13 (lane 5) and PR15
(lane 7). DNA from all 28 of the PR mutants retained the
restriction site (data not shown), indicating that the orig-
inal mutation introduced into KUL26-610/611 was present
in each of the revertants. Therefore, all of the spontane-
ous revertants were the result of mutations at a second
site. The insertion of the mutation in the parental virus
(KUL26-610/611) that blocked the maturation cleavage
site of the scaffold proteins and insertion of the EcoRI
estriction site was done by altering four bases from the
ild-type sequence. Reverting to the original amino acid
equence of Ala-Ser would require only two base
hanges because of the redundacy of the genetic code,
ut is still unlikely to occur spontaneously.
NA sequence analysis of the UL19 (VP5) ORF of the
evertants
Since mutations were the result of second-site muta-
ions and those reported previously were in the N-termi-
al region of the gene encoding VP5, we proceeded
irectly with a DNA sequence analysis of the viral DNA of
he gene encoding VP5 for all the revertant viruses pro-
eeding from the 59 to the 39 direction of the UL19 ORF.
DNA base changes that caused amino acid substitutions
were found for all of the mutants, and the data are
summarized in Table 1. The DNA codon change and the
resulting amino acid substitution are shown in columns
2 and 3, respectively. For comparison, the data obtained
previously (for PR1 to PR9) are shown in bold print. PR3
was the result of two mutations in the VP5 gene and was
deleted from the table. Three revertants of the present
study also contained multiple mutations: PR17 (codons
55 [D3 N] and 85 [P3 L]), PR45 (codons 24 [L3 F] and
40 [S3 F]), and PR46 (codons 205 [L3M], 297 [D3 N],
and 327 [R 3 Q]), and were not studied further. VP5
contains 1374 amino acids. Single DNA base changes
FIG. 2. Genetic analysis of the revertant viruses. A 659-bp C-terminal
fragment of UL26 was amplified by PCR for KOS (lanes 2 and 3) and
revertant viruses PR13 (lanes 4 and 5) and PR15 (lanes 6 and 7).
Aliquots of amplified DNA were cut with EcoRI (lanes 3, 5, and 7). A
no-template control (lane 8) and 100-bp markers (lane 1) are also
shown. The positions of the 659-bp and cleaved products (247 and 416
bp) are shown at the right side of the figure.that resulted in amino acid substitutions were observed
between codons 34 and 80 for 15 of the 25 revertants. PThe remaining 10 revertants were found to have amino
acid substitutions in the remaining portion of VP5. Thus,
60% of all the second-site revertants were in a 47-amino-
acid stretch at the N-terminus and the other 40% were in
a broad region of 1152 amino acids (residues 166
through 1317). Six of these last 10 from this study were
clustered between residues 187 and 383. The remaining
four were near the C-terminus of VP5 at residues 882
(PR34), 1080 (PR14, PR28), and 1317 (PR35). These last
four of the 28 revertants had no representatives in the
eight mutants studied earlier. For the mutants shown in
Table 1A, DNA in the UL19 ORF was sequenced from
codon 1 to codon 150 (450 bp). For Table 1B, PR34, PR14,
PR28, and PR35 had the entire UL19 ORF (1374 codons)
sequenced; the others were sequenced through codon
400. Although we cannot rule out the possibility that
some of these revertants have additional mutations not
yet located, of the 28 new revertants isolated in this
study, three of the 28 (or 10.7%) had multiple mutations.
This is similar to the earlier study where one of nine
revertants had multiple mutations when approximately
one-third of the gene was sequenced. All four revertants
whose entire UL19 ORF was completely sequenced had
only one mutation each.
In this study revertants reported at the N-terminus
TABLE 1
Mutations in the Gene Encoding UL19 (VP5)
of the Revertant Viruses
Mutant(s) Codon change
Amino acid
change
A. PR viruses with mutations between residues 30–80 of UL19
PR9a GCG3 GTG 30 A3 V
PR5, PR10, PR22, PR40 CGC3 CAC 34 R3 H
R33 CGC3 TGC 34 R3 C
R13, PR44 CGC3 TGC 41 R3 C
R7, PR30 CGC3 TGC 69 R3 C
R2, PR6, PR8, PR18, PR19, PR24,
PR32, PR38, PR41, PR47 GCG3 GTG 78 A3 V
PR42 GTG3 ATG 80 V3M
B. PR viruses with mutations between residues 166–1317 of UL19
R4 GCT3 ACT 166 A3 T
R25 GTG3 ATG 187 V3M
R39 CCG3 TCG 193 P3 S
R23 GTC3 ATC 274 V3 I
R15 GTC3 GCC 317 V3 A
R1 GCG3 GTG 319 A3 V
R37 ATG3 ACG 322 M3 T
R43 CGC3 CAC 383 R3 H
R34 GGG3 AGG 882 G3 R
R14, PR28 GTG3 ATG 1080 V3M
PR35 TGC3 TAC 1317 C3 Y
a Revertants in bold are those reported previously by Desai and
erson (1999).
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220 WARNER, DESAI, AND PERSONincluded seven additional mutants at residue 78, result-
ing in the same A 3 V change. Four revertants were
utated at residue 34, three gave rise to the same amino
cid substitution (R3 C), and the fourth one was R3 H.
There was one additional mutant at residue 69 (R 3 C).
he mutations at residues 34, 69, and 78 included the
ame amino acid substitutions as reported previously.
hree mutants were at two new sites at codons 41 (R3
) and 80 (V 3 M).
Although we did not directly sequence the entire UL19
RF of KOS (wild-type) we did sequence it for several
utants. Any change from the reported sequence of
train 17 (McGeoch et al., 1988) that was present in all
mutants was assumed to be a difference between the
two wild-type strains. In addition to the changes from
strain 17 at the N-terminal end that were reported in the
previous study at residues 36, 50, 58, 154, 272, 375, 377,
and 550 (Desai and Person, 1999), there were additional
base changes in codons 619, 713, 721, 739, 766, 768, 796,
848, 852, 1083, 1098, 1138, and 1345. The base changes
at 154, 375, 619, 848, 852, and 1098 resulted in the
following amino acid replacements: G 3 S, V 3 I, D 3
E, A3 T, E3 D, and A3 G, respectively. The other base
changes were silent mutations.
Western blots of scaffold proteins
To confirm that there were no new cleavage sites in
the scaffold proteins of the revertant viruses isolated, we
examined the proteins of the revertant viruses by sodium
dodecyl sulfate (SDS)–polyacrylamide gel electrophore-
sis (PAGE). If the second-site mutations arose from
changes in VP5 alone, and no new scaffold protein cleav-
age sites were created, then the mobility of the scaffold
proteins (21 and the more prevalent 22a) for the revertant
viruses is expected to be the same as that for KUL26-
610/611 and less than that found for KOS (Desai and
Person, 1999; Person and Desai, 1998). In one set of the
experiments infected cells were radioactively labeled
from 8 to 24 h after infection, and nuclear lysates were
prepared and sedimented through sucrose gradients.
Collected fractions were analyzed for radioactivity and
examined by SDS–PAGE. The resulting gels of B capsid
fractions showed scaffold proteins of decreased mobility
relative to KOS and no evidence of additional low-molec-
ular-weight bands that would indicate secondary cleav-
age of scaffold proteins (data not shown). We used West-
ern blots to examine the mobility of scaffold proteins
more clearly. Infected cell proteins were prepared using
revertant viruses that represented each of the amino acid
substitutions reported in the previous section. Infected
cell proteins of each PR mutant as well as KOS and
KUL26-610/611 were separated on SDS–PAGE, trans-
ferred to Immobilon, and probed with antibody to the
scaffold proteins. The western blots are shown in Figs.
3A and 3B. The revertants are arranged from left to rightin order of increasing codon altered. For example, PR10
and PR33 (at the left of Fig. 3A) had a DNA substitution at
codon 34 for the two different amino acid insertions (see
legend of Fig. 3). The scaffold proteins of all the PR
mutants as well as the parental virus (KUL26-610/611)
have decreased mobilities than those of the KOS scaffold
proteins, indicating that the scaffold proteins of the mu-
tants remained uncleaved. The signal corresponding to
uncleaved protein 21 for the revertants PR10 and PR42
(Fig. 3A) appears to be greater than that for the other
revertants, the result of an artifact of the gel. The proteins
in those lanes were compressed, as evidenced by the
circular appearance of the radioactivity. This had the
visual effect of an apparent increase in the levels of 21.
The radioactivity corresponding to the scaffold proteins
for the revertant PR35 was decreased in this blot. We
believe this was the result of a variation in the infected
cell lysate that was loaded onto the gel. In other sedi-
mentation experiments PR35 gave capsids containing
levels of 22a comparable to those of the other revertants.
Single-step growth of the revertants
Growth of the revertant viruses yielded smaller
plaques and lower titers than those of wild-type virus. To
obtain a better quantification, single-step growth exper-
iments were performed as described previously (Desai
and Person, 1999). Duplicate confluent monolayers of
Vero cells in six-well trays were infected at a multiplicity
of infection (m.o.i.) of 10 plaque-forming units (PFU)/cell.
At 24 h postinfection infected cells were harvested, son-
FIG. 3. (A and B) Western blots of scaffold proteins of PR mutants.
Vero cells were infected with KOS, KUL26-610/611 (labeled 610/611),
and PR mutants at a m.o.i. of 10 PFU/cell. Infection was allowed to
proceed for 24 h. Cells were harvested, pelleted, and resuspended in
Laemmli’s buffer. Samples were then run on SDS–PAGE gels (9%
acrylamide), and proteins probed with antibody MCA406 (Serotec,
Raleigh, NC), a monoclonal antibody to the scaffold proteins (21 and
22a). Scaffold proteins are indicated on the left for KOS and on the right
for the mutants (*). PR10 (R3 H) and PR33 (R3 C) were the result of
changes in codon 34, PR13 at 41, PR18 at 78, PR42 at 80, PR25 at 187,
PR39 at 193, PR23 at 274, PR15 at 317, PR37 at 322, PR43 at 383, PR34
at 882, PR14 at 1080, and PR35 at 1317.icated, and virus titered. Results are shown in Table 2.
KOS had an average burst size of 914 PFU/cell with a
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221INTERACTIONS BETWEEN HSV-1 VP5 AND SCAFFOLDstandard deviation of 164, based on six experiments with
a range of 717 to 1167 PFU/cell. All of the mutant viruses
had greatly reduced burst sizes relative to those of KOS.
These tests were done in groups of five to 11, with the
KOS controls repeated each time. The percentage of KOS
of each mutant is therefore calculated relative to the KOS
done within that experiment. Some revertants were done
more than once and those revertants showed similar
results when repeated. Burst sizes of the PR mutants
ranged from 2% to 18% of the KOS control, but no specific
pattern in burst size was seen relative to the location of
the mutation in the coding sequence of VP5. In the
previous study, similar results for burst size of revertants
were obtained, with the burst sizes ranging from 4% to
16% of KOS (Desai and Person, 1999).
Temperature sensitivity of the revertants
When representative mutants of each altered residue
were plated at 39.5°C as well as at 37°C, the results
showed varying amounts of sensitivity to elevated tem-
perature. Wild-type (KOS) plated at the elevated temper-
ature with an efficiency of 73% relative to 37°C, so results
of all mutants were expressed relative to those of wild-
type. PR30, mutated at residue 69 (R3 C), was the most
sensitive, where the efficiency was only 0.1% of KOS.
PR15 (317 V3 A), PR43 (383 R3 H), and PR39 (193 P3
S) plated at 3, 5, and 12%, respectively, of the wild-type.
PR18 and PR45 were less sensitive to temperature and
their plating efficiency was 38 and 45%, respectively,
relative to that of KOS. The others showed no significant
change from the wild-type. Although there was variation
TABLE 2
Single-Step Growth of Mutants Relative to KOS
Virus
Average burst
sizea
Percentage
relative to KOS
within an
experiment
Amino acid
change
KOS 913 6 164 100 —
PR33 26 4 34 R3 C
R10 74 10 34 R3 H
R13 175 18 41 R3 C
R18 174 15 78 A3 V
R42 94 8 80 V3M
R25 151 16 187 V3M
R39 22 3 193 P3 S
R23 17 2 274 V3 I
R15 103 11 317 V3 A
R37 132 14 322 M3 T
R43 24 3 383 R3 H
R34 56 6 882 G3 R
R14 27 3 1080 V3M
R35 23 3 1317 C3 Y
a Burst size was calculated using 7.5 3 105 cells/well.in the response to temperature, no pattern was detected
relative to the location of the altered residue.
t
cAnalysis of PR mutations in UL19 (VP5) transferred
into the KOS background
Mutations in the VP5 molecule of previously isolated
viruses (PR5, PR6, and PR7) were introduced into the
KOS background, to determine the effect of these muta-
tions on virus growth and capsid maturation in the pres-
ence of scaffold proteins that are cleaved at the matura-
tion site. These three revertants were chosen because
one (PR5) was temperature independent and the other
two (PR6 and PR7) had modest temperature sensitivity
for plaque formation. In addition PR7 seemed to be the
most compromised of those revertants studied previ-
ously and showed no interaction with the scaffold pro-
teins in the yeast two-hybrid system (Desai and Person,
1999).
The PR5, PR6, and PR7 mutations were transferred to
the KOS background using a marker-transfer/marker-
rescue technique. The viral DNA was derived from KD5Z,
which was deleted for the (UL19) VP5 coding sequence
(Desai et al., 1993). Plasmid DNA encoding UL19 was
derived from PR5, PR6, and PR7. Using this assay the PR
mutations could be readily transferred into the virus
genome and at the same time the deletion of UL19 in
K5DZ would be rescued. This rescue assay allows one to
select for recombinants by their ability to replicate on
Vero cells, unlike the parental virus (KD5Z), which re-
quires a complementing cell line. Following cotransfec-
tion on permissive cells, the lysate was examined for
virus that could form plaques on Vero cells. Plaques
appeared on Vero cells for all the transfections, indica-
tive of rescue of the VP5 mutation in KD5Z. DNA se-
quence determination of the 59 region of UL19 (VP5)
confirmed the presence of each mutation. These viruses
were designated PR5K, PR6K, and PR7K to denote that
the original mutations in VP5 are present in a KOS UL26
genome.
The status of the scaffold proteins and the viral pro-
tease. To determine the status of scaffold cleavage, 35S-
ethionine-labeled B capsids of PR5, PR5K, PR6, PR6K,
R7, and PR7K were prepared and examined by SDS–
AGE (Fig. 4). The bands representing the scaffold pro-
eins are marked with short arrows. The transfer of each
R mutation encoded in VP5 (PR5K, PR6K, and PR7K) into
he KOS background resulted in an increased mobility of
he scaffold proteins. The mobility was also the same as
or KOS. The mobility in the presence of the KUL26-610/
11 mutation was decreased relative to that of KOS.
Previous quantification of the retention of VP24 in B
apsids of PR mutants estimated that there were 35
olecules of VP24 retained per capsid, as opposed to
ild-type virus capsids, which retained approximately
40 molecules of VP24 per capsid (Desai and Person,
999). The parental virus (KUL26-610/611) of the PR mu-
ants retained even less VP24, approximately 10 mole-
ules per capsid (Desai and Person, 1999). To examine
222 WARNER, DESAI, AND PERSONthe relative amounts of VP24 present in PR5K, PR6K, and
PR7K, C capsids from the same experiments were also
examined by SDS–PAGE and were compared with those
of PR5, PR6, and PR7 (Fig. 5). The results shown in Fig.
5 show that PR5K and PR6K retained VP24 in amounts
that were similar to that for KOS, and was increased
relative to the mutants, which in addition encode a
blocked cleavage site in UL26. PR7K and PR7, by con-
trast, appeared to retain similar amounts of VP24, both
retaining noticeably less than that in KOS. All of the new
PR mutants isolated in this study showed a reduction in
the retention of VP24 in the B capsids when compared to
the amount retained in KOS (data not shown).
Virus yields and temperature sensitivities. The PR mu-
tants isolated in a KOS background (as PR5K, PR6K, and
PR7K), and therefore using the wild-type UL26 gene
products but with the VP5 mutation, were also tested for
their growth properties in Vero cells. Results are shown
in Table 3A. KOS had a burst size of 1167 PFU/cell. PR5K
and PR6K each had at least wild-type burst sizes of 1400
and 1174 PFU/cell (or 120 and 101% of KOS, respectively),
indicating that the mutation in VP5 in these mutants did
not have a deleterious effect on the growth of the virus.
The burst sizes for PR5 and PR6 were, respectively, 11
and 6% of KOS. By contrast, PR7K had a burst size of only
246 or 21% of that of KOS (relative to 9% of KOS for PR7).
Therefore, the VP5 second-site mutation of PR7 still had
a negative effect on viral growth in a wild-type back-
ground.
FIG. 4. B capsids formed by the PR mutants in the presence of
wild-type and mutant maturation cleavage sites. Infected Vero cells
were labeled with 35S-methionine from 8 to 24 h postinfection. Cells
were harvested and capsids isolated by sedimentation through su-
crose gradients. Samples corresponding to the B capsids were ana-
lyzed by SDS–PAGE (15% acrylamide). B capsids were isolated from
PR5, PR6, and PR7 (lanes 2, 4, and 6, respectively) and those without
the blocked cleavage site PR5K, PR6K, and PR7K (lanes 3, 5, and 7
respectively). KOS is in lane 1. Scaffold proteins (21 and 22a) in the PR
mutants are indicated by arrows. The smallest capsid protein, VP26,
ran off the end of the gel.When the PR5, PR6, and PR7 mutations were grown in
a KOS background (as PR5K, PR6K, and PR7K), the tem-perature sensitivity to 39.5°C was retained in PR6K and
PR7K (Table 3B), indicating the mutations in VP5 for PR6
and PR7 had an adverse effect on the protein when
grown at an elevated temperature. The effect of the PR5
mutation was minimal by this assay. In summary, the
temperature sensitivity of PR6 and PR7 resides in VP5
and was similar in the presence or absence of blocked
scaffold cleavage sites. We also determined the virus
yields following a single-cycle growth of PR7 and PR6 at
34 and 37°C. The virus yields at these two temperatures
were comparable; in fact, they were slightly lower at
34°C, presumably because of the slower kinetics at this
temperature (data not shown). Therefore, the PR mutants
are not temperature-sensitive at 37°C.
DISCUSSION
The virus KUL26-610/611 was engineered to contain a
block at the scaffold protein cleavage site. Although the
mutation was lethal, spontaneous reversions arise at a
frequency of 1 in 3800. In the present study 25 revertant
viruses were isolated that had a single amino acid res-
idue altered in the gene encoding VP5. In addition eight
viruses had been isolated previously, giving a total of 33
viruses with single amino acid changes in VP5. All of the
viruses are able to replicate and overcome the blocked
cleavage site. Presumably all of the revertants weaken
the interaction between VP5 and the C-terminus of the
UL26 gene products, so the scaffold is free of VP5 and
able to leave the capsids in the absence of cleavage at
the maturation site. Evidence for blocked cleavage sites
was indicated by results at the DNA (Fig. 2) and protein
(Fig. 3) levels. Although revertants are obtained at a very
FIG. 5. The levels of VP24 in C capsids of the PR mutants in the
presence and absence of maturation site cleavage. Vero cells were
infected at a m.o.i. of 10 PFU/cell and labeled with 35S-methionine 8 to
24 h postinfection. Cells were harvested and capsids isolated by
sedimentation through sucrose gradients. Proteins in the fractions
corresponding to C capsids were analyzed by SDS–PAGE (15% acryl-
amide). Gels were dried and proteins visualized by autoradiography.
The capsid proteins are indicated on the left side of the gel. The
smallest capsid protein, VP26, ran off the end of the gel.
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223INTERACTIONS BETWEEN HSV-1 VP5 AND SCAFFOLDhigh frequency, the plaques are very small compared to
those of wild-type, and the burst size ranges from 2% to
18% of wild-type ranges. To form a capsid there must be
a VP5–scaffold protein interaction; for virus infection to
proceed, the interaction must be sufficiently weak to
allow scaffold molecules to be free to leave capsids.
Therefore, the mutations are able to overcome the block,
but only to the extent that virus replication is decreased
by an order of magnitude.
For the 33 spontaneous revertants characterized, 10
had changes at codon 78. All were changes in the DNA
encoding the middle base of codon 78 and resulted in
the amino acid substitution of A 3 V. An additional five
evertants were altered at codon 34; four were changes
n the middle base of 34 and gave an R3 H amino acid
substitution. The remaining substitution was R 3 C,
resulting from a change in the 59 base position. In addi-
tion to these mutants, two revertants also occurred at
codon 41 (R 3 C) and two at codon 69 (R 3 C). A total
of 21 of the 33 spontaneous revertants were found within
the DNA encoding residues 30 to 80 of VP5, which
contains 1374 amino acids. Approximately 65% of the
TABLE 3
Growth and Temperature Sensitivity of PR Mutants in the Presence
and Absence of the Maturation Site Cleavage
A. Single step growth of PR mutants relative to KOS
Virus
Average burst
sizea
Percentage
relative to KOS
within an
experiment
Amino acid
change
KOS 1167 100
PR5 129 11 34 R 3 H
PR5Kb 1400 120 34 R 3 Hb
PR6 75 6 78 A 3 V
PR6Kb 1174 100 78 A 3 Vb
PR7 100 9 69 R 3 C
R7Kb 246 21 69 R 3 Cb
B. Temperature sensitivity of plaque formation at 39.5°C relative to 37°C
Virus
Plaquing
efficiency
(39.5/37°C)
Percentage
of KOS
Amino acid
change
KOS 0.69 100
PR5 0.46 66 34 R 3 H
PR5Kb 0.64 93 34 R 3 Hb
PR6 0.14 20 78 A 3 V
PR6Kb 0.10 16 78 A 3 Vb
PR7 0.006 1 69 R 3 C
PR7Kb 0.016 3 69 R 3 Cb
a Burst size was calculated using 7.5 3 105 cells/well.
b These mutants have the respective VP5 mutation indicated but
have the wild-type maturation cleavage site in the UL26/U126.5 ORF
(i.e., in the KOS background).mutants studied were contained in a 51-amino-acid
stretch near the N-terminus of VP5, and 15 of the 33 (45%)caused amino acid substitution at only two residues (34
and 78). This is the most striking result of the combined
studies. Within this N-terminal 51-amino-acid region,
spontaneous revertants were found at a total of six sites
(Fig. 6). All of the revertants in this region are found in
two stretches of 12 amino acids each (30 through 41 and
69 through 80).
The remaining 12 revertants (35%) occurred over the
1152 residues beyond the extreme N-terminus of VP5.
Two revertants were found that altered codon 1080. Eight
of the 12 were located between codons encoding 166
and 383, with two of these eight reported in the original
study. Altogether, the 33 revertants occurred at a total of
17 sites (amino acids). Part of the reason for the high
spontaneous reversion frequency is because of the ex-
istence of multiple sites in a large molecule that can give
rise to revertants.
Production of a revertant virus depends on the amino
acid substitution and its position within VP5. Multiple
isolates at the same nucleotide implies that there was
something special about those changes. Fifteen of the
revertants occur at positions 34 and 78, 14 of which
result from changes at two nucleotides; these residues
are unique. An additional six revertants were found be-
tween residues 30 and 41 and between residues 69 and
80. These two stretches of 12 amino acids in VP5 may
interact directly with C-terminal residues of the scaffold
proteins and we prefer to believe this may be part of the
explanation of their high frequency of occurrence. If
these two short regions of VP5 (amino acids 30 through
41 and 69 through 80) do interact directly with scaffold
proteins, then synthetic peptides comprised of these
residues could possibly reduce virus growth. Reversion
at the other more C-terminal sites could alter the inter-
FIG. 6. N-terminal mutated residues of VP5. Amino acid sequences
of VP5 from residue 30 to 41 and from residue 69 to 80 indicate the
location (as shown below the sequence) and number of revertants in
the N-terminus of VP5. The residue numbers are indicated in the top
line, and the number of each change is indicated (in the bottom line)
under the altered residue. The two phenylalanines at positions 36 and
70 are completely conserved in the following herpesviruses: herpes
simplex type 1 (HSV-1) and type 2 (HSV-2), pseudorabies virus (PRV),
equine herpesvirus-1 (EHV-1), bovine herpesvirus 1 (BHV1), varicella-
zoster virus (VZV), turkey herpesvirus 2 (THV-2), human herpesvirus 5
(HHV5), human herpesvirus 8 (HHV8), equine herpesvirus-2 (EHV-2),
Epstein–Barr virus (EBV), murine herpesvirus 68 (MHV68), Alcelaphine
herpesvirus 1 (Ahv1), human herpes virus 6 (HHV6), human herpesvirus
7 (HHV7), human cytomegalovirus (HCMV), simian cytomegalovirus
(SCMV), and murine cytomegalovirus (MCMV). The underlined resi-
dues are conserved or have only conservative substitutions in the
alpha herpesviruses (HSV-1, HSV-2, PRV, EHV-1, BHV1, and VZV).
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224 WARNER, DESAI, AND PERSONaction directly or indirectly, if the changes alter the con-
formation of VP5 during capsid maturation from a spher-
ical to an icosahedral form.
If some of the altered residues (e.g., at 34 and at 78) do
interact with scaffold molecules, one may wonder
whether changes in the region of the scaffold that inter-
acts with VP5 would also lead to reversion. The answer
is in the affirmative, as an additional revertant has been
isolated that is altered at residue 630 (UL26) of the
scaffold proteins (to be published separately).
There are three characteristics of these second-site
mutations in VP5: (1) the virus growth and plaque size
are markedly reduced; (2) mutants retain a decreased
amount of VP24 in the capsids; and (3) some of the
mutants showed some degree of sensitivity to tempera-
ture. These characteristics were altered to differing de-
grees when the second-site mutation was put into a KOS
background that then utilized scaffold proteins that were
cleaved normally at the maturation cleavage site. The
results for two of the mutants (PR5 and PR6) grown in the
KOS background indicate that the mutated residues have
no detrimental effect on the virus, and the amount of
VP24 retained in the C capsids also appears to be at a
wild-type level. The growth of PR7 in a wild-type back-
ground, however, increased the virus yield only twofold
and had little effect on VP24 retention. PR6 and PR7 had
some temperature sensitivity, which is unchanged in the
wild-type background. Thus, the temperature-sensitive
phenotype reflects a temperature sensitivity of the mu-
tated VP5 molecules. Finally, the results regarding VP24
indicate that it may play a structural role in capsid as-
sembly in addition to the known role as the protease as
proposed originally by Gao and colleagues (1996) and
supported by Desai and Person (1999).
Using the PHD Predict Protein program (Rost and
Sander, 1993), two long a-helices (residues 21–43 and
7–73) are predicted at the N-terminus of VP5, with a
hort b-sheet following the second a-helix. Residues
ltered between 30 to 41 fall into the first helix, while
hose of 69 to 80 indicate a region that is predicted to
nclude some of the second a-helix and the b-sheet. The
mino acid sequence from residues 30 to 41 and from 69
o 80 with the altered residues is shown in Fig. 6. Resi-
ues that are conserved in either all herpesviruses or all
a herpesviruses are indicated on the figure, along with
he locations and frequency of the mutations in the re-
ertant viruses. None of our spontaneous mutations oc-
urred at any of the conserved sites, but were within the
a-helices or the b-sheet. Recently, Zhou et al. (2000)
showed by cryoelectronmicroscopy of B capsids at 8.5-Å
resolution that there are two long a-helices separated by
a slight bend on the floor domain, which would be the
interior of the capsid where one would expect the inter-
action with the scaffold proteins to occur, however there
are other long helices in the more C-terminal portions of
the protein as well, so further studies on the proteinstructure and interactions are needed to identify resi-
dues and a secondary structure of VP5 that interacts with
the scaffold proteins.
MATERIALS AND METHODS
Cells and viruses
Cells and viruses were maintained as described pre-
viously (Desai et al., 1998). A previously described trans-
formed cell line (C32) that makes all essential capsid
proteins (VP5, VP19C, 21, 22a, VP23, and VP24) and a
mutant virus (KUL26-610/611) blocked at the UL26 matu-
ration cleavage site were used in this study (Person and
Desai, 1998).
Isolation of revertant viruses
The mutant virus KUL26-610/611 was plated in 96-well
trays on the transformed cell line (C32) at 1.5 PFU/well.
Each well contained 2.5 3 104 cells. Virus and cells were
mixed before dispensing the mixture into wells. Wells
containing single plaques were harvested and plated on
Vero cells (nonpermissive cells for KUL26-610/611), again
in 96-well trays. Those viruses that produced plaques on
Vero cells were then picked and subjected to two addi-
tional cycles of plaque purification in 96-well trays. In all
cases wells were chosen that contained a single plaque.
After a plaque-purified isolate was obtained, a viral stock
of each mutant was grown on Vero cells.
Marker transfer of PR mutations into the KOS
background
Marker transfer of the PR mutations into the KOS
background was essentially carried out as described in
Person and Desai (1998). A marker-transfer/marker-res-
cue assay was used. The goal was to use plasmids
encoding the KpnII fragment of PR5, PR6, and PR7 (Desai
and Person, 1999). These plasmids contain the se-
quences that encode UL18–UL20 (McGeoch et al., 1988),
including the PR mutation in the UL19 gene. Cotransfec-
tion of these plasmids with DNA from the VP5 null mutant
K5DZ (Desai et al., 1993) would rescue the null mutation
in that virus and transfer the PR mutation into a wild-type
background. Subconfluent monolayers of C32 cells
(0.5 3 106) in 60-mm dishes were cotransfected with 1
mg linearized plasmid DNA and 2 mg of K5DZ-infected
cell DNA. When foci were observed (48 h after transfec-
tion) the cell monolayers were harvested, freeze/thawed
once, and sonicated, and the total virus progeny were
titered. Single-plaque isolates were tested for their ability
to plate on Vero cells. The isolates that formed plaques
on Vero cells represent viruses in which the VP5 null
mutation had been rescued. These isolates were further
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225INTERACTIONS BETWEEN HSV-1 VP5 AND SCAFFOLDplaque-purified three times prior to characterization.
These viruses were designated PR5K, PR6K, and PR7K.
The relevant region of the UL19 gene from these viruses
was sequenced and this analysis confirmed the intro-
duction of the PR mutations into the KOS genome.
Viral DNA isolation, amplification, and sequence
determination
Viral DNA for each mutant was obtained by infecting
wells of Vero cells (1.5 3 105 cells/well) of a 24-well tray
ith m.o.i. 5 10 (10 PFU/cell) of each virus. The infected
ells were harvested 24 h postinfection, pelleted, resus-
ended in phosphate-buffered saline (PBS), lysed, and
igested by proteinase-K by the addition of an equal
olume of digestion buffer containing 20 mM Tris–HCl,
H 8.0, 20 mM EDTA, 1.2% sodium dodecyl sulfate (SDS),
nd 500 mg/ml proteinase-K (Roche Molecular Biochemi-
als, Indianapolis, IN) and incubated for 3 h at 37°C. The
NA was then phenol/chloroform extracted three times,
thanol-precipitated, and resuspended in 50 ml TE (pH
.5). The C-terminal end of UL26/UL26.5 of each mutant
as amplified by PCR using Taq polymerase (Roche
olecular Biochemicals). The forward primer (59-GG-
ACCAACGAGACCATC) used for this PCR started at
odon 473 of the UL26 coding sequence and the reverse
rimer (59-CCCCACGCCTTCCTCCAC) started 167 bases
eyond the UL26/UL26.5 stop codon. The mutation (Ala-
er to Glu-Phe) at 610–611 of the scaffold proteins in the
arental virus generated an EcoRI restriction site which
as used to check for the retention of the mutation. The
roduct (659 bp) was cut with EcoRI (New England Bio-
abs, Beverly, MA) and run on a 1.5% agarose gel, to
onfirm the retention of the blocked maturation cleavage
ite of UL26.
For DNA sequencing, PCR was then carried out on the
ene encoding VP5 (UL19) in six overlapping segments
hat could be sequenced from one or both directions.
his PCR was done with PfuTurbo polymerase (Strat-
gene, La Jolla, CA), to minimize the incorporation of
CR-induced errors. The forward primers were 18-bp
ligonucleotides, whose 59 nucleotides corresponded to
1 nucleotides upstream of the start codon and to nucle-
tides 358, 1127, 1867, 2444, and 3101 relative to the start
f translation of the UL19 ORF. The corresponding re-
erse primers were 18-bp oligonucleotides with the 59
ucleotides corresponding to nucleotides 459, 1240,
956, 2636, 3235 relative to the start of translation and 67
ases beyond the stop codon for the UL19 ORF. These
CR reactions yielded products of 501, 883, 830, 770, 792,
nd 1074 bp. The PCR products were cleaned up with the
iagen PCR cleanup kit and both strands sequenced by
he DNA Analysis Facility of Johns Hopkins School of
edicine using an ABI 3700 sequencer. Analysis of theesulting traces was done by the DNA Analysis Facility
taff with Sequencher (GeneCodes, Ann Arbor, MI).
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